학술논문

Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma
Document Type
Article
Source
In: Oncologist. (Oncologist, February 2024, 29(2):142-150)
Subject
Language
English
ISSN
1549490X
10837159